As a type of chemotherapy drug, BiCNU® (carmustine) is approved to treat the following types of cancer:
- Brain tumors
- Multiple myeloma (a cancer of the bone marrow)
- Hodgkin's lymphoma
- Non-Hodgkin's lymphoma.
BiCNU belongs to a group of medicines known as alkylating agents. This medicine contains the active drug carmustine, which is sometimes referred to by its chemical name, bis-chloroethylnitrosourea (BCNU). This chemotherapy drug works by preventing DNA strands from replicating. As a result, cancer cells are unable to grow and multiply correctly.